Self-administered v. Provider-administered: How route of administration in oncology products affects payer coverage and product strategy.

Contact Person : Marketing; Last Date for the submission of abstract : Not Available ; Description : View our on-demand webcast. Learn how the shift in therapy administration could impact all stakeholders: pharmaceutical manufacturers, providers, patients and payers.

Comments

Order by:

expand all

Per page:

There are no comments yet

Location

Location is undefined

Edit Location

Venues

Empty

Rate

0 votes

Recommend

Home

›

Events

›

Self-administered v. Provider-administered: How route of administration in oncology products affects payer coverage and product strategy.

About Us Privacy Terms FAQ Contact Us